News
12-14-2010, 03:30 AM
"We provide optimal care to breast cancer patients when we treat the underlying biology of their individual tumors," said Steven Shak, MD, chief medical officer of Genomic Health.
More... (http://www.news-medical.net/news/20101214/Genomic-Health-announces-results-of-Oncotype-DX-test-in-early-stage-breast-cancer-patients.aspx)
More... (http://www.news-medical.net/news/20101214/Genomic-Health-announces-results-of-Oncotype-DX-test-in-early-stage-breast-cancer-patients.aspx)